The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 32.70
High: 32.70
Low: 32.70
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New office and university partnerships in Scotland

27 Oct 2015 07:00

RNS Number : 4867D
Mercia Technologies PLC
27 October 2015
 

RNS Reach

27 October 2015

 

Mercia Technologies PLC

 

Mercia expands regional footprint with new office and university partnerships in Scotland

 

Mercia Technologies PLC (AIM: Merc, "Mercia"), a Midlands-based investment group building, funding and commercialising technology businesses across the UK, has opened an Edinburgh office and secured partnerships with Abertay University and the University of Strathclyde, to reinforce its support for early stage Scottish businesses. The office will be headed by Paul Devlin, who joins Mercia as Investment Manager, Scotland.

 

Located in central Edinburgh, the office will allow Mercia to bolster its commitment to finding and investing in disruptive, scalable technology businesses in Scotland, which is largely underserved by later stage investors despite its impressive variety of start-ups and spinouts.

 

Paul Devlin, who ran the LAUNCH.ed student company formation service at the University of Edinburgh until joining Mercia, will build a team in Scotland to increase Mercia's deal flow and provide the company with new and exciting investment opportunities. Paul has a strong track record as an entrepreneur and supporter of early stage businesses and has a wealth of expertise in market and technology assessment, academic and industrial collaborations, company formation and IP commercialisation.

 

Mercia's partnerships with Abertay University, which has notable strengths in the digital sector, and the University of Strathclyde, which excels in life sciences, manufacturing and electronics, will provide Mercia with a pipeline of new investment opportunities.

 

Mercia now has 11 partnerships with universities across the Midlands, the North and Scotland, with a dedicated technology transfer team to support spinout companies through to commercialisation. Spinouts from these partners now provide approximately 50% of all investments via Mercia's third party funds, managed by its wholly-owned subsidiary, Mercia Fund Management (MFM).

 

As a result, MFM recently successfully raised its University Growth Fund, a tax-efficient SEIS and EIS fund, which will be used to support university spinouts from Mercia's partners across the UK.

 

Mark Payton, CEO of Mercia Technologies, said:

 

"When we listed on AIM last year to scale our established model of informed and patient capital provision, Mercia made a clear statement of intent - that it was a national business with a strong focus on the Midlands, the North and Scotland, all of which are a hotbed of technology-led innovators struggling to find supportive investment.

 

"In 2014, £2.7bn was invested across the South East of England in venture capital against less than £300m across all of Scotland. We look forward to working with Scottish entrepreneurs to address this imbalance, with our focused investment activity and expertise, managed by industry-leading investment directors who have built highly successful businesses in each of the sectors we support."

 

Commenting on the opening of the Edinburgh office and his appointment, Paul Devlin said:

"This a fantastic opportunity to help scale up Scotland's existing start-ups and support the next breakthrough ideas. Mercia is well placed to support this, both through participating at later stage Series A investment, and also through its award winning SEIS and EIS investment funds. I look forward to heading these initiatives throughout Scotland and to working with the Mercia team."

 

Commenting on the new partnership, Stuart Mackenzie, Commercialisation Infrastructure Manager at the University of Strathclyde, said:

 

"The University is delighted to have added Mercia Technologies to our list of preferred investment partners. We have been impressed by Mercia's success in raising new funds in a difficult market, and by Mercia's commitment to expanding its geographic footprint.

 

"Since adopting a commercial investment policy in 2012, the University has invested over £1m in spinout company funding rounds led by established early-stage investors. We welcome the addition of Mercia to this list and look forward to participating in Mercia-led funding rounds."

 

Mark Batho, Vice-Principal and Deputy Vice Chancellor (University Services) at Abertay University, said:

 

"We're delighted to establish this partnership with Mercia Technologies. Their track record and expertise in providing specialist input to university start-ups, particularly in the digital sector, will be valuable in encouraging and supporting the creativity and dynamism for which our students are known."

 

For further information contact:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Martin Glanfield, Chief Financial Officer

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu (Nomad) / Mark Connelly

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen / Lauren Foster

 

Note to editors

Mercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands, the North and Scotland. It brings technology transfer, company formation, incubation, commercialisation and investment to technology ventures. Approximately 50% of its investments derive from university spinouts. Mercia invests across key technology sectors in which it has deep sector expertise.

 

The Mercia model is one of patiently nurturing businesses through its tax efficient third party funds under management, and then scaling them with direct investment at the point of commercial traction. Through this, Mercia has a well seeded portfolio and pipeline of investments - its 'emerging stars'.

 

Mercia's shares started trading on AIM on 18 December 2014 and since then up until 31 July 2015, Mercia has invested almost £15m directly across its portfolio of emerging stars, which in themselves have attracted total investment of over £70m alongside investment from the Group. In addition to its direct investments, Mercia (via Mercia Fund Management) has invested over £20m to build its portfolio of potential emerging stars.

 

Paul Devlin

Paul has worked in innovative technical and commercial environments throughout his 16 year career, making the transition from an engineer, patent holding researcher and company founder to a commercially focused senior programme manager, consultant and advisor.

 

Paul worked at Scottish Enterprise from 2009 to 2011 as a Senior Programme Manager, where he performed an extended ITI role which included commercialisation, research portfolio management and business process integration implemented to PRINCE2 and MSP guidelines.

 

From there, he worked at New Media Partners as a Senior Consultant, before moving on to the University of Edinburgh, first as a Senior Company Formation Executive, then as a Student Company Formation Manager.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAXEKASSSFFF
Date   Source Headline
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.